On April 9, 2010
Novartis Sex-Discrimination Case: The Horrible Downside of Tolerating “Bad Apples”
Novartis (NVS) appears to be trying to blame a few bad apples in the barrel for the $200 million sex discrimination trial currently under way in a New York federal court. But Novartis’ real problem is that by failing to
…
0 Comments